MedDataX Logo

Increasing COVID-19 Vaccine Uptake in Developing Countries (Bihar)

NCT05225064 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114512

Last updated 2022-06-22

No results posted yet for this study

Summary

Working with governments in Bihar, India, we will evaluate a number of mechanisms to increase vaccine uptake. These include household vaccination visits instead of community vaccination clinic.monetary and non-monetary incentives, and concurrent mask promotion. This ClinicalTrials entry contains results only for the study in Bihar.

Conditions

  • Vaccination Refusal

Interventions

BEHAVIORAL

Incentives to be vaccinated

Individuals will be provided with a guaranteed cash payment, entry into a cash lottery, or guaranteed gift of food if they are vaccinated

DEVICE

Mask

Individuals are given cloth masks

BEHAVIORAL

Encouragement to wear a mask

Individuals who are not wearing masks over their mouth and nose are stopped in public places and encouraged to wear a mask

BEHAVIORAL

Vaccination made more convenient

Vaccines are conducted at the household-level rather than the village-level

BEHAVIORAL

Social mobilization campaign to be vaccinated

Village-level social mobilization campaign to be vaccinated

Sponsors & Collaborators

  • University of Connecticut

    collaborator OTHER

  • Lahore University of Management Sciences

    collaborator OTHER

  • University of California, Berkeley

    collaborator OTHER

  • Innovations for Poverty Action

    collaborator OTHER

  • Yale University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-19
Primary Completion
2022-04-27
Completion
2022-04-27

Countries

  • India

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05225064 on ClinicalTrials.gov